| Substance | Relationship Strength | Studies | Trials | Classes | Roles |
|---|
carbazilquinone
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients. | 1.99 | 1 | 0 | organic molecular entity | |
vitamin k 3
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo. | 1.99 | 1 | 0 | 1,4-naphthoquinones;
vitamin K | angiogenesis inhibitor;
antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human urinary metabolite;
nutraceutical |
quinone
benzoquinone : The simplest members of the class of benzoquinones, consisting of cyclohexadiene which is substituted by two oxo groups.. 1,4-benzoquinone : The simplest member of the class of 1,4-benzoquinones, obtained by the formal oxidation of hydroquinone to the corresponding diketone. It is a metabolite of benzene.. quinone : Compounds having a fully conjugated cyclic dione structure, such as that of benzoquinones, derived from aromatic compounds by conversion of an even number of -CH= groups into -C(=O)- groups with any necessary rearrangement of double bonds (polycyclic and heterocyclic analogues are included). | 2.67 | 3 | 0 | 1,4-benzoquinones | cofactor;
human xenobiotic metabolite;
mouse metabolite |
uracil mustard
Uracil Mustard: Nitrogen mustard derivative of URACIL. It is a alkylating antineoplastic agent that is used in lymphatic malignancies, and causes mainly gastrointestinal and bone marrow damage. | 1.97 | 1 | 0 | aminouracil;
nitrogen mustard | |
triaziquone
Triaziquone: Alkylating antineoplastic agent used mainly for ovarian tumors. It is toxic to skin, gastrointestinal tract, bone marrow and kidneys.. triaziquone : A member of the class of 1,4-benzoquinones that is 1,4-benzoquinone in which three of the ring hydrogens are replaced by aziridin-1-yl groups. | 2.39 | 2 | 0 | 1,4-benzoquinones;
aziridines | alkylating agent;
antineoplastic agent |
1,4-naphthoquinone
naphthoquinone : A polycyclic aromatic ketone metabolite of naphthalene.. 1,4-naphthoquinone : The parent structure of the family of 1,4-naphthoquinones, in which the oxo groups of the quinone moiety are at positions 1 and 4 of the naphthalene ring. Derivatives have pharmacological properties. | 1.99 | 1 | 0 | 1,4-naphthoquinones | |
2,5-dimethyl-4-benzoquinone
[no description available] | 1.99 | 1 | 0 | | |
2-methyl-1,4-benzoquinone
cresoquinone: no further information available 6/2003 | 1.99 | 1 | 0 | | |
2-chloro-1,4-naphthoquinone
2-chloro-1,4-naphthoquinone: Vitamin K dependent carboxylase antagonist | 1.99 | 1 | 0 | 1,4-naphthoquinones;
organochlorine compound | |
2-amino-3-chloro-1,4-naphthoquinone
2-amino-3-chloro-1,4-naphthoquinone: has antineoplastic activity; structure in first source | 1.99 | 1 | 0 | 1,4-naphthoquinones | |
diaziquone
diaziquone: RN given refers to parent cpd. diaziquone : A 1,4-benzoquinone that is substituted at positions 2 and 5 have been replaced by aziridin-1-yl groups and at positions 3 and 6 by (ethoxycarbonyl)amino groups. | 3.59 | 9 | 0 | 1,4-benzoquinones;
aziridines;
carbamate ester;
enamine | alkylating agent;
antineoplastic agent |
duroquinone
tetramethyl-1,4-benzoquinone: structure in first source. duroquinone : A member of the class of 1,4-benzoquinones that is 1,4-benzoquinone in which all four hydrogens are substituted by methyl groups. | 1.99 | 1 | 0 | 1,4-benzoquinones | |
2,6-dimethyl-1,4-benzoquinone
[no description available] | 1.99 | 1 | 0 | | |
2-bromo-1,4-naphthoquinone
2-bromo-1,4-naphthoquinone: structure in first source | 1.99 | 1 | 0 | | |
nsc 30705
NSC 30705: RN given refers to parent cpd; structure given in first source | 2.39 | 2 | 0 | | |
ethylenimine quinone
2,5-bis(aziridin-1-yl)-1,4-benzoquinone : A member of the class of 1,4-benzoquinones that is p-benzoquinone in which the hydrogens at positions 2 and 5 are replaced by aziridin-1-yl groups. | 2.68 | 3 | 0 | 1,4-benzoquinones;
aziridines | alkylating agent;
mutagen |
2,5-dimethyl-3,6-diaziridinyl-1,4-benzoquinone
2,5-dimethyl-3,6-diaziridinyl-1,4-benzoquinone: structure given in first source | 2.39 | 2 | 0 | | |
sorafenib
[no description available] | 2.25 | 1 | 0 | (trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
phenylureas;
pyridinecarboxamide | angiogenesis inhibitor;
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
ferroptosis inducer;
tyrosine kinase inhibitor |
2-methylamino-1,4-naphthoquinone
2-methylamino-1,4-naphthoquinone: structure in first source | 1.99 | 1 | 0 | | |